Article Abstract

Video-assisted thoracoscopic surgery lobectomy: transitions in practice

Authors: Andrew P. Dhanasopon, Daniel J. Boffa


Video-assisted thoracoscopic surgery (VATS) is widely accepted as a standard approach for the surgical treatment of stages I and II non-small cell lung cancers (NSCLC) (1). Two meta-analyses (2,3), four large United States database studies (4-7), and several retrospective single-institution studies (8-13) have demonstrated that VATS lobectomy is associated with fewer complications (pulmonary, atrial fibrillation), transfusion rate, pain, and length of hospital stay without compromising oncologic outcomes when matched for stage. Despite the benefits of VATS compared to thoracotomy, the adoption of this technique has progressed slowly, with only 44% of lobectomies being performed by VATS in the U.S. in 2014 (14) and only 27% in Europe (15).